Most research peptides have never been near a regulatory filing. Sermorelin was an approved drug in the 1980s — and that history is exactly why its research base stands apart.
Sermorelin was the first GHRH analog to earn FDA approval, sold as Geref for diagnosing and treating growth hormone deficiency in children. The branded product left the U.S. market in 2008 for commercial reasons, not safety — and the compound remains one of the most extensively studied GH secretagogues in clinical medicine, including its continued use as a diagnostic test for GH reserve.
Sermorelin is the shortest fragment of GHRH that still fully activates the receptor — 29 amino acids, nothing extra. It binds GHRH receptors on the pituitary and triggers GH gene transcription upstream, working inside the body’s existing feedback loops rather than replacing GH directly. Research suggests that preserves the natural pulsatile release pattern instead of flattening it.
Clinical research in elderly adults found measurable IGF-1 increases within two to four weeks of administration, sustained throughout the treatment period — solid confirmation that the receptor is being engaged as intended.
Sermorelin’s approval history applies specifically to pediatric GH-deficiency diagnosis and treatment; the research-use compound sold today is a different product from that original pharmaceutical.
Yes — approved as Geref for pediatric GH deficiency in the 1980s, withdrawn in 2008 for commercial reasons, not safety.
Different receptor. Sermorelin binds the GHRH receptor. Ipamorelin binds the ghrelin receptor. Different upstream mechanism, same downstream target.
Elderly adults showed measurable IGF-1 increases within two to four weeks, sustained throughout treatment — a strong, repeatable marker of receptor engagement.
Sources Reviewed
1. Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev. 1993.
2. Prakash A, Goa KL. Sermorelin: a review of its use in diagnosis and treatment of idiopathic GH deficiency. Paediatr Drugs. 1999.
View Sermorelin 10mg -> bravalongevity.com/product/sermorelin-10mg/
This content is a literature review for research and educational purposes only. Brava Longevity products are sold strictly for research use only (RUO) and are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease. Statements have not been evaluated by the FDA.
